Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 3
2016 7
2017 4
2018 1
2019 13
2020 16
2021 13
2022 15
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Granulomatous hepatitis with Crohn's disease: a case report.
Suzuki T, Hayakawa Y, Kaneko S, Takenaka K, Watakabe K, Kinowaki Y, Takemoto A, Ohtsuka K, Asahina Y, Okamoto R. Suzuki T, et al. Among authors: kaneko s. Clin J Gastroenterol. 2024 Mar 19. doi: 10.1007/s12328-024-01937-8. Online ahead of print. Clin J Gastroenterol. 2024. PMID: 38502473
Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
Kaneko S, Asahina Y, Murakawa M, Azuma S, Inada K, Mochida T, Watakabe K, Shimizu T, Tsuchiya J, Miyoshi M, Kawai-Kitahata F, Nitta S, Takahashi M, Fujioka T, Kishino M, Anzai T, Kakinuma S, Nakagawa M, Okamoto R. Kaneko S, et al. PLoS One. 2024 Mar 7;19(3):e0297882. doi: 10.1371/journal.pone.0297882. eCollection 2024. PLoS One. 2024. PMID: 38452155 Free PMC article.
Prognostic significance of C-reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Kaneko S, Asahina Y, Murakawa M, Ueyama S, Maeyashiki C, Watanabe H, Kusano-Kitazume A, Sato A, Uchidate K, Asakawa T, Watanabe S, Iizuka Y, Shibata I, Oooka S, Karakama Y, Fujii T, Watabe T, Akahoshi K, Tanabe M, Inada K, Mochida T, Watakabe K, Shimizu T, Tsuchiya J, Miyoshi M, Kitahata-Kawai F, Nitta S, Nakagawa M, Kakinuma S, Okamoto R; Ochanomizu Liver Conference Study Group. Kaneko S, et al. Hepatol Res. 2023 Dec 22. doi: 10.1111/hepr.14001. Online ahead of print. Hepatol Res. 2023. PMID: 38133587
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population.
Kirino S, Tamaki N, Kurosaki M, Takahashi Y, Higuchi M, Itakura Y, Tanaka Y, Inada K, Ishido S, Yamashita K, Nobusawa T, Matsumoto H, Hayakawa Y, Kakegawa T, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Tsuchiya K, Nakanishi H, Okamoto R, Izumi N. Kirino S, et al. Among authors: kaneko s. Quant Imaging Med Surg. 2023 Oct 1;13(10):6493-6502. doi: 10.21037/qims-23-511. Epub 2023 Aug 28. Quant Imaging Med Surg. 2023. PMID: 37869309 Free PMC article.
Molecular-Level Structural Analysis of siRNA-Loaded Lipid Nanoparticles by 1H NMR Relaxometry: Impact of Lipid Composition on Their Structural Properties.
Ueda K, Sakagawa Y, Saito T, Fujimoto T, Nakamura M, Sakuma F, Kaneko S, Tokumoto T, Nishimura K, Takeda J, Arai Y, Yamamoto K, Ikeda Y, Higashi K, Moribe K. Ueda K, et al. Among authors: kaneko s. Mol Pharm. 2023 Sep 4;20(9):4729-4742. doi: 10.1021/acs.molpharmaceut.3c00477. Epub 2023 Aug 22. Mol Pharm. 2023. PMID: 37606988
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.
Keitoku T, Tamaki N, Kurosaki M, Inada K, Kirino S, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Ishido S, Yamada M, Nobusawa T, Matsumoto H, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Asahina Y, Okamoto R, Izumi N. Keitoku T, et al. Among authors: kaneko s. J Viral Hepat. 2023 Apr;30(4):297-302. doi: 10.1111/jvh.13805. Epub 2023 Jan 24. J Viral Hepat. 2023. PMID: 36648382
69 results